138 related articles for article (PubMed ID: 30287917)
21. Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis.
Gamper AM; Qiao X; Kim J; Zhang L; DeSimone MC; Rathmell WK; Wan Y
Mol Cell; 2012 Jan; 45(2):233-43. PubMed ID: 22284679
[TBL] [Abstract][Full Text] [Related]
22. Krüppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF-β1/Smad/snail pathway.
Leng Z; Li Y; Zhou G; Lv X; Ai W; Li J; Hou L
J Cell Mol Med; 2020 Jan; 24(2):1866-1877. PubMed ID: 31830379
[TBL] [Abstract][Full Text] [Related]
23. High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients.
Lee HY; Ahn JB; Rha SY; Chung HC; Park KH; Kim TS; Kim NK; Shin SJ
World J Surg Oncol; 2014 Jul; 12():232. PubMed ID: 25060774
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
J Cell Mol Med; 2020 Jan; 24(2):1878-1892. PubMed ID: 31881124
[TBL] [Abstract][Full Text] [Related]
25. Krüppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer.
Jie Y; He W; Yang X; Chen W
Cancer Gene Ther; 2017 Sep; 24(9):361-366. PubMed ID: 28752861
[TBL] [Abstract][Full Text] [Related]
26. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
27. Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium.
Ghaleb AM; Aggarwal G; Bialkowska AB; Nandan MO; Yang VW
Mol Cancer Res; 2008 Dec; 6(12):1920-7. PubMed ID: 19074836
[TBL] [Abstract][Full Text] [Related]
28. HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation.
Huang Y; Chen J; Lu C; Han J; Wang G; Song C; Zhu S; Wang C; Li G; Kang J; Wang J
Cell Death Dis; 2014 Oct; 5(10):e1491. PubMed ID: 25341045
[TBL] [Abstract][Full Text] [Related]
29. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
30. MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma.
Mao Q; Quan T; Luo B; Guo X; Liu L; Zheng Q
Tumour Biol; 2016 Jan; 37(1):463-71. PubMed ID: 26224477
[TBL] [Abstract][Full Text] [Related]
31. Expression profiles of circular RNAs in human colorectal cancer based on RNA deep sequencing.
Ge J; Jin Y; Lv X; Liao Q; Luo C; Ye G; Zhang X
J Clin Lab Anal; 2019 Sep; 33(7):e22952. PubMed ID: 31169949
[TBL] [Abstract][Full Text] [Related]
32. Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.
Morris VA; Cummings CL; Korb B; Boaglio S; Oehler VG
Mol Cell Biol; 2016 Feb; 36(4):559-73. PubMed ID: 26644403
[TBL] [Abstract][Full Text] [Related]
33. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
34. Acetylbritannilactone suppresses growth via upregulation of krüppel-like transcription factor 4 expression in HT-29 colorectal cancer cells.
Fang XM; Liu B; Liu YB; Wang JJ; Wen JK; Li BH; Han M
Oncol Rep; 2011 Nov; 26(5):1181-7. PubMed ID: 21811764
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.
Ma B; Zhang L; Zou Y; He R; Wu Q; Han C; Zhang B
J Exp Clin Cancer Res; 2019 Jan; 38(1):23. PubMed ID: 30658712
[TBL] [Abstract][Full Text] [Related]
36. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066
[TBL] [Abstract][Full Text] [Related]
37. Krüppel-Like Factor 4 Overexpression Initiates a Mesenchymal-to-Epithelial Transition and Redifferentiation of Human Pancreatic Cells following Expansion in Long Term Adherent Culture.
Muir KR; Lima MJ; Docherty HM; McGowan NW; Forbes S; Heremans Y; Forbes SJ; Heimberg H; Casey J; Docherty K
PLoS One; 2015; 10(10):e0140352. PubMed ID: 26457418
[TBL] [Abstract][Full Text] [Related]
38. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
[TBL] [Abstract][Full Text] [Related]
39. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
[TBL] [Abstract][Full Text] [Related]
40. Doxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells.
Chen Z; Wang Y; Liu W; Zhao G; Lee S; Balogh A; Zou Y; Guo Y; Zhang Z; Gu W; Li C; Tigyi G; Yue J
PLoS One; 2014; 9(8):e105331. PubMed ID: 25137052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
